Lymphoma Associated studies
Open trials
Short name | ZUMA-2 cohort 3 |
Study title | A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2) |
Status | Open in AUMC (AMC), EMC & UMCG |
Medication | KTE-X19 |
Population | r/r MCL BTKi-naive (i.e. Ibrutinib, Acalabrutinib) |
Study docs | Subject eligibility |
Short name | HD21 |
Study title | Treatment optimization trial in the first line treatment of adv stage HL: comparison of 4-6 cycles of esc BEACOPP with 4-6 cycles of BrECADD |
Status | Open |
Participants | AmsterdamUMC - VUmc- JM Zijlstra MeanderMC – JC Regelink Jeroen Bosch ziekenhuis- H Pruijt ADR ziekenhuis Goes- S Kuipers OLVG A’dam – A. Gerrits WFG Hoorn- C Klerk Haga ziekenhuis- L Bohmer LUMC- H Veelken Anthonius ziekenhuis- M Sohne |
Study docs | Flow + eligibility Protocol |